Boston Scientific (BSX) still tilts bearish

We received an inquiry on Boston Scientific (BSX).

Our The Stock Pulse report on November 21, 2025, highlighted this stock as bearish. BSX stalled where it was supposed to, which was at the declining 13, 26, and 40-week moving averages at 100-102, in late November and early December and then dropped into the downside target zone for the April to September bearish (rising) wedge from 90.69 to 85.98 (October and April 2025 lows).

Exhibit 1: Boston Scientific (BSX) from The Stock Pulse from November 21, 2025

In our view, BSX remains bearish until proven otherwise.

Declining 13-, 26-, and 40-week moving averages (WMAs), confirmed by bearish WMAs relative to the S&P 500, remain an overhang from 95.55 into the 98.34-100.27 range with chart resistances at 97.27 and 100.90. Rallies on BSX that do not reclaim these levels keep the 90.69 to 85.98 range exposed to downside tests. This range includes 100% extension levels at 86.84-85.67, but if BSX moves to lower lows below the April 2025 low at 85.98, it would suggest deeper risk to 161.8% extension levels at 76.25-75.21.

Chart 2: Boston Scientific (BSX) (top) and relative to the S&P 500 (bottom): Weekly chart

The 14-week RSI (price momentum) broke down in advance of the April-September 2025 rising wedge on BSX's absolute price chart. Lower lows for RSI confirmed the lower tactical lows for BSX.

MACD remains on a bearish signal within negative territory, which could provide an overhang.

*Note that BSX is scheduled to report earnings before the market opens on Wednesday, February 4.

Chart 3: Boston Scientific (BSX) (top), 14-week RSI (center), and MACD (bottom): Weekly chart